nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—P-Glycoprotein Inhibitors—Cyclosporine—focal segmental glomerulosclerosis	0.41	0.521	CiPCiCtD
Amiodarone—Cytochrome P450 3A4 Inhibitors—Cyclosporine—focal segmental glomerulosclerosis	0.377	0.479	CiPCiCtD
Amiodarone—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0277	0.172	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0277	0.172	CbGbCtD
Amiodarone—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0208	0.129	CbGbCtD
Amiodarone—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.02	0.124	CbGbCtD
Amiodarone—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0167	0.104	CbGbCtD
Amiodarone—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0864	CbGbCtD
Amiodarone—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0839	CbGbCtD
Amiodarone—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.079	CbGbCtD
Amiodarone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0081	0.0503	CbGbCtD
Amiodarone—Cerebellar ataxia—Cyclosporine—focal segmental glomerulosclerosis	0.0076	0.162	CcSEcCtD
Amiodarone—Pustular psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0076	0.162	CcSEcCtD
Amiodarone—Acute respiratory distress syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.0375	CcSEcCtD
Amiodarone—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0342	CcSEcCtD
Amiodarone—Benign intracranial hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0333	CcSEcCtD
Amiodarone—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0315	CcSEcCtD
Amiodarone—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0307	CcSEcCtD
Amiodarone—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0293	CcSEcCtD
Amiodarone—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0274	CcSEcCtD
Amiodarone—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0262	CcSEcCtD
Amiodarone—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.000745	0.0159	CcSEcCtD
Amiodarone—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.0139	CcSEcCtD
Amiodarone—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.0138	CcSEcCtD
Amiodarone—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.0116	CcSEcCtD
Amiodarone—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.000537	0.0115	CcSEcCtD
Amiodarone—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.0111	CcSEcCtD
Amiodarone—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.000504	0.0108	CcSEcCtD
Amiodarone—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.000458	0.00978	CcSEcCtD
Amiodarone—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.000442	0.00944	CcSEcCtD
Amiodarone—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.00918	CcSEcCtD
Amiodarone—CACNA1H—NCAM1 interactions—COL4A4—focal segmental glomerulosclerosis	0.000407	0.0826	CbGpPWpGaD
Amiodarone—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000381	0.00812	CcSEcCtD
Amiodarone—CACNA1H—NCAM1 interactions—COL4A1—focal segmental glomerulosclerosis	0.000374	0.0759	CbGpPWpGaD
Amiodarone—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.000372	0.00793	CcSEcCtD
Amiodarone—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.0079	CcSEcCtD
Amiodarone—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.0079	CcSEcCtD
Amiodarone—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000359	0.00765	CcSEcCtD
Amiodarone—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000356	0.00759	CcSEcCtD
Amiodarone—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000352	0.00752	CcSEcCtD
Amiodarone—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00749	CcSEcCtD
Amiodarone—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000349	0.00746	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000344	0.00733	CcSEcCtD
Amiodarone—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.00727	CcSEcCtD
Amiodarone—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00033	0.00704	CcSEcCtD
Amiodarone—CACNA1H—NCAM1 interactions—COL4A3—focal segmental glomerulosclerosis	0.000316	0.0641	CbGpPWpGaD
Amiodarone—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000293	0.00626	CcSEcCtD
Amiodarone—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN4—focal segmental glomerulosclerosis	0.000283	0.0573	CbGpPWpGaD
Amiodarone—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000283	0.00603	CcSEcCtD
Amiodarone—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000282	0.00601	CcSEcCtD
Amiodarone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.00558	CcSEcCtD
Amiodarone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00555	CcSEcCtD
Amiodarone—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.0055	CcSEcCtD
Amiodarone—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.00538	CcSEcCtD
Amiodarone—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000251	0.00536	CcSEcCtD
Amiodarone—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00025	0.00533	CcSEcCtD
Amiodarone—CACNA1H—NCAM signaling for neurite out-growth—COL4A4—focal segmental glomerulosclerosis	0.000239	0.0486	CbGpPWpGaD
Amiodarone—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.00491	CcSEcCtD
Amiodarone—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000222	0.00473	CcSEcCtD
Amiodarone—CACNA1H—NCAM signaling for neurite out-growth—COL4A1—focal segmental glomerulosclerosis	0.00022	0.0446	CbGpPWpGaD
Amiodarone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00458	CcSEcCtD
Amiodarone—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000214	0.00456	CcSEcCtD
Amiodarone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000206	0.00439	CcSEcCtD
Amiodarone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000203	0.00434	CcSEcCtD
Amiodarone—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000196	0.00419	CcSEcCtD
Amiodarone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00403	CcSEcCtD
Amiodarone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000188	0.004	CcSEcCtD
Amiodarone—CACNA1H—NCAM signaling for neurite out-growth—COL4A3—focal segmental glomerulosclerosis	0.000186	0.0377	CbGpPWpGaD
Amiodarone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.00397	CcSEcCtD
Amiodarone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000184	0.00393	CcSEcCtD
Amiodarone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00391	CcSEcCtD
Amiodarone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000181	0.00385	CcSEcCtD
Amiodarone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.00384	CcSEcCtD
Amiodarone—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00373	CcSEcCtD
Amiodarone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.00363	CcSEcCtD
Amiodarone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000168	0.0036	CcSEcCtD
Amiodarone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00356	CcSEcCtD
Amiodarone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00352	CcSEcCtD
Amiodarone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00349	CcSEcCtD
Amiodarone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00349	CcSEcCtD
Amiodarone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000162	0.00347	CcSEcCtD
Amiodarone—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.00342	CcSEcCtD
Amiodarone—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000159	0.00339	CcSEcCtD
Amiodarone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000158	0.00337	CcSEcCtD
Amiodarone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000156	0.00333	CcSEcCtD
Amiodarone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.00316	CcSEcCtD
Amiodarone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.00313	CcSEcCtD
Amiodarone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00311	CcSEcCtD
Amiodarone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000144	0.00307	CcSEcCtD
Amiodarone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000142	0.00303	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000141	0.00301	CcSEcCtD
Amiodarone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000141	0.00301	CcSEcCtD
Amiodarone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.00298	CcSEcCtD
Amiodarone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.00298	CcSEcCtD
Amiodarone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.00287	CcSEcCtD
Amiodarone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00285	CcSEcCtD
Amiodarone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00013	0.00277	CcSEcCtD
Amiodarone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000129	0.00276	CcSEcCtD
Amiodarone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000129	0.00276	CcSEcCtD
Amiodarone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00012	0.00257	CcSEcCtD
Amiodarone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.0025	CcSEcCtD
Amiodarone—THRA—Endochondral Ossification—SPP1—focal segmental glomerulosclerosis	0.000116	0.0236	CbGpPWpGaD
Amiodarone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.00247	CcSEcCtD
Amiodarone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000112	0.00239	CcSEcCtD
Amiodarone—CACNA2D2—Regulation of insulin secretion—GNAQ—focal segmental glomerulosclerosis	0.00011	0.0223	CbGpPWpGaD
Amiodarone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000108	0.00231	CcSEcCtD
Amiodarone—THRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000105	0.0213	CbGpPWpGaD
Amiodarone—THRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000105	0.0213	CbGpPWpGaD
Amiodarone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000104	0.00222	CcSEcCtD
Amiodarone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000103	0.0022	CcSEcCtD
Amiodarone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000103	0.0022	CcSEcCtD
Amiodarone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000102	0.00219	CcSEcCtD
Amiodarone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	9.71e-05	0.00207	CcSEcCtD
Amiodarone—CACNA1H—Axon guidance—MYH10—focal segmental glomerulosclerosis	9.29e-05	0.0188	CbGpPWpGaD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—GNAQ—focal segmental glomerulosclerosis	8.98e-05	0.0182	CbGpPWpGaD
Amiodarone—CACNA2D2—Integration of energy metabolism—GNAQ—focal segmental glomerulosclerosis	8.64e-05	0.0175	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—COL4A4—focal segmental glomerulosclerosis	6.87e-05	0.0139	CbGpPWpGaD
Amiodarone—ADRB1—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	6.82e-05	0.0138	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MYH10—focal segmental glomerulosclerosis	6.63e-05	0.0134	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—COL4A1—focal segmental glomerulosclerosis	6.31e-05	0.0128	CbGpPWpGaD
Amiodarone—THRA—Endochondral Ossification—MMP9—focal segmental glomerulosclerosis	6.2e-05	0.0126	CbGpPWpGaD
Amiodarone—ADRB1—Endothelin Pathways—EDN1—focal segmental glomerulosclerosis	6.15e-05	0.0125	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—COL4A3—focal segmental glomerulosclerosis	5.33e-05	0.0108	CbGpPWpGaD
Amiodarone—THRA—Endochondral Ossification—TGFB1—focal segmental glomerulosclerosis	5.11e-05	0.0104	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MYH9—focal segmental glomerulosclerosis	5.09e-05	0.0103	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	4.9e-05	0.00994	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	4.5e-05	0.00913	CbGpPWpGaD
Amiodarone—CYP1A1—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	4.44e-05	0.009	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—TRPC6—focal segmental glomerulosclerosis	3.92e-05	0.00795	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.84e-05	0.00778	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	3.81e-05	0.00772	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	3.68e-05	0.00745	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	3.68e-05	0.00745	CbGpPWpGaD
Amiodarone—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	3.63e-05	0.00736	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MYH9—focal segmental glomerulosclerosis	3.63e-05	0.00736	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.38e-05	0.00685	CbGpPWpGaD
Amiodarone—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	3.34e-05	0.00677	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	2.98e-05	0.00604	CbGpPWpGaD
Amiodarone—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	2.83e-05	0.00574	CbGpPWpGaD
Amiodarone—CACNA1H—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	2.8e-05	0.00569	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	2.8e-05	0.00568	CbGpPWpGaD
Amiodarone—ADRB1—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	2.37e-05	0.00481	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.34e-05	0.00475	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	2.14e-05	0.00433	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	2.12e-05	0.0043	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	2.09e-05	0.00424	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2e-05	0.00406	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	1.9e-05	0.00385	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	1.87e-05	0.0038	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	1.84e-05	0.00372	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	1.82e-05	0.00369	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—CTGF—focal segmental glomerulosclerosis	1.77e-05	0.00359	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—CTGF—focal segmental glomerulosclerosis	1.77e-05	0.00359	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—LPL—focal segmental glomerulosclerosis	1.76e-05	0.00357	CbGpPWpGaD
Amiodarone—EBP—Metabolism—LIPC—focal segmental glomerulosclerosis	1.71e-05	0.00347	CbGpPWpGaD
Amiodarone—THRB—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	1.68e-05	0.0034	CbGpPWpGaD
Amiodarone—THRA—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	1.68e-05	0.0034	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MMP2—focal segmental glomerulosclerosis	1.65e-05	0.00335	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	1.57e-05	0.00319	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	1.56e-05	0.00316	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.54e-05	0.00312	CbGpPWpGaD
Amiodarone—EBP—Metabolism—CTGF—focal segmental glomerulosclerosis	1.5e-05	0.00305	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	1.44e-05	0.00292	CbGpPWpGaD
Amiodarone—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	1.4e-05	0.00284	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	1.4e-05	0.00284	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	1.39e-05	0.00282	CbGpPWpGaD
Amiodarone—EBP—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.39e-05	0.00281	CbGpPWpGaD
Amiodarone—CYP1A1—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	1.27e-05	0.00257	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MMP9—focal segmental glomerulosclerosis	1.24e-05	0.00252	CbGpPWpGaD
Amiodarone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	1.24e-05	0.00252	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	1.24e-05	0.00251	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.22e-05	0.00247	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	1.2e-05	0.00243	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	1.19e-05	0.00241	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MMP2—focal segmental glomerulosclerosis	1.18e-05	0.00239	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	1.17e-05	0.00238	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.07e-05	0.00217	CbGpPWpGaD
Amiodarone—EBP—Metabolism—LPL—focal segmental glomerulosclerosis	1.04e-05	0.00211	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	1.02e-05	0.00206	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.88e-06	0.002	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	9.13e-06	0.00185	CbGpPWpGaD
Amiodarone—EBP—Metabolism—AGT—focal segmental glomerulosclerosis	8.92e-06	0.00181	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MMP9—focal segmental glomerulosclerosis	8.87e-06	0.0018	CbGpPWpGaD
Amiodarone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	8.55e-06	0.00173	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	8.44e-06	0.00171	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	8.07e-06	0.00164	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	8.07e-06	0.00164	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	7.88e-06	0.0016	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	7.74e-06	0.00157	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—LPL—focal segmental glomerulosclerosis	7.43e-06	0.00151	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	7.31e-06	0.00148	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	7.08e-06	0.00143	CbGpPWpGaD
Amiodarone—EBP—Metabolism—ALB—focal segmental glomerulosclerosis	6.85e-06	0.00139	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	6.75e-06	0.00137	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	6.71e-06	0.00136	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	6.58e-06	0.00134	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.52e-06	0.00132	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	6.42e-06	0.0013	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	6.4e-06	0.0013	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AGT—focal segmental glomerulosclerosis	6.36e-06	0.00129	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	6.34e-06	0.00129	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.13e-06	0.00124	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.09e-06	0.00124	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.98e-06	0.00121	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	5.83e-06	0.00118	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.74e-06	0.00116	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	5.64e-06	0.00114	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.34e-06	0.00108	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.26e-06	0.00107	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	5.16e-06	0.00105	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.12e-06	0.00104	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	4.92e-06	0.000998	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ALB—focal segmental glomerulosclerosis	4.88e-06	0.000989	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.87e-06	0.000987	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.81e-06	0.000974	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.7e-06	0.000953	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.69e-06	0.00095	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.37e-06	0.000887	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.28e-06	0.000869	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	4.25e-06	0.000862	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.16e-06	0.000843	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.98e-06	0.000807	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.97e-06	0.000805	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.9e-06	0.00079	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	3.74e-06	0.000759	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.66e-06	0.000742	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.65e-06	0.00074	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.63e-06	0.000736	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.62e-06	0.000734	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.6e-06	0.00073	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.45e-06	0.000699	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	3.43e-06	0.000696	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.4e-06	0.00069	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.3e-06	0.000669	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.26e-06	0.00066	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.16e-06	0.000641	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.16e-06	0.000641	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.12e-06	0.000633	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	3.07e-06	0.000623	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.03e-06	0.000614	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.97e-06	0.000602	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.9e-06	0.000589	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.79e-06	0.000565	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.77e-06	0.000561	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.71e-06	0.000549	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	2.66e-06	0.00054	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.61e-06	0.00053	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.59e-06	0.000526	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.56e-06	0.000518	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.54e-06	0.000515	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.54e-06	0.000514	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.49e-06	0.000506	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.39e-06	0.000486	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	2.38e-06	0.000482	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	2.38e-06	0.000482	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.36e-06	0.000478	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.35e-06	0.000476	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	2.34e-06	0.000475	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.32e-06	0.00047	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.28e-06	0.000462	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	2.22e-06	0.00045	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.19e-06	0.000443	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.17e-06	0.00044	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.17e-06	0.000439	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.16e-06	0.000438	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.16e-06	0.000437	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.14e-06	0.000433	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	2.09e-06	0.000424	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.04e-06	0.000414	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	2.03e-06	0.000413	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.98e-06	0.000402	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.95e-06	0.000395	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.95e-06	0.000395	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.93e-06	0.000391	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.92e-06	0.00039	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.91e-06	0.000387	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.88e-06	0.000381	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	1.88e-06	0.00038	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.85e-06	0.000375	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.8e-06	0.000365	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.77e-06	0.000359	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.77e-06	0.000359	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.76e-06	0.000356	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.7e-06	0.000345	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.67e-06	0.000338	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.63e-06	0.000331	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.62e-06	0.000329	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.6e-06	0.000325	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	1.56e-06	0.000317	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.52e-06	0.000307	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.5e-06	0.000305	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.5e-06	0.000304	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.45e-06	0.000294	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.43e-06	0.00029	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.42e-06	0.000287	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	1.39e-06	0.000282	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.33e-06	0.00027	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.32e-06	0.000268	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.26e-06	0.000255	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.24e-06	0.000252	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.23e-06	0.00025	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.21e-06	0.000246	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.16e-06	0.000236	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.16e-06	0.000235	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.15e-06	0.000233	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.14e-06	0.000231	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.13e-06	0.000229	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.13e-06	0.000229	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.07e-06	0.000216	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	9.67e-07	0.000196	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	9.52e-07	0.000193	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.45e-07	0.000192	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	9.29e-07	0.000188	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	8.76e-07	0.000178	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	8.72e-07	0.000177	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	8.68e-07	0.000176	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	7.46e-07	0.000151	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	7.42e-07	0.00015	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	5.72e-07	0.000116	CbGpPWpGaD
